Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Search
Main sub menu
Investors
Careers
Working at Recipharm
The Recipharm story
Meet our employees
Current vacancies
Contact
Contact us
Development services contacts
Manufacturing services contacts
Locations
Main navigation
Development
Drug substance
Drug product
Analytical chemistry
Clinical trial material (CTM)
Manufacturing
Solids
Semi-solids
Liquids
Inhalation
Injectables
Ophthalmics
Solutions
Recipharm Pathway to Clinic®
Serialisation
Learn
Press & events
Press
Events
Reports
Insights
Our story
Recipharm in brief
Business model
Business overview
Sustainability
Company history
Press & events
What's happening?
Stay updated on our latest news and events.
Press and Event
Press
Events
Reports
Insights
Displaying 1 - 10 of 49
Subscribe
Show all
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Press
Regulatory approval received for acquisition of Kemwell Indian operations
2016.12.30
Read more
Press
Chief Financial Officer to leave Recipharm
2016.12.19
Read more
Press
Recipharm bolsters development business with new appointments in the US and Europe
2016.12.14
Read more
Press
Recipharm and Laccure agree commercial collaboration
2016.12.01
Read more
Press
Interim report January-September 2016
2016.11.10
Read more
Press
Invitation to presentation of Recipharm’s interim report for the third quarter 2016 on the 10th November
2016.11.07
Read more
Press
Recipharm invests in its Italian API facility
2016.11.02
Read more
Press
Recipharm to open new GLP bioanalysis laboratory in Sweden
2016.10.17
Read more
Press
Recipharm launches serialisation showcase line
2016.10.03
Read more
Press
Recipharm successfully places SEK 1,000m senior unsecured convertible bonds
2016.09.29
Read more
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Next page
Next ›
Last page
Last »
